PO.MCB08.01 · 分子与细胞生物学

The perturbation data gap: Accelerating discovery with CRISPR screening

海报缩略图:The perturbation data gap: Accelerating discovery with CRISPR screening
编号 498 展板 10 时间 4/19 02:00–05:00 区域 Section 20 主讲 Jessica Martyn
分会场 Genomic Dissection to Define Novel Therapeutic Strategies
查看完整资料 下载 PDF 登录后可访问当前开放资料 AACR 官方页面 ↗

作者与单位

Elena Vialetto1, Ronay Cetin1, Sebastian Süsser2, Simran Rastogi1, Angela Hinchie1, Jessica Martyn1, Martin Wegner1, Manuel Kaulich1

1Vivlion GmbH, Frankfurt am Main, Germany,2IBCII, Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany

摘要 Abstract

At Vivlion, we continually strive to enhance CRISPR library and screening solutions. We introduce Alexandria, our flagship genome-wide PRCISR™ CRISPR knockout library, available in single-targeting and fixed-pair formats. The fixed-pair design delivers two sgRNAs per cell for the same gene (or predefined gene pairs), boosting editing efficiency and enabling combinatorial strategies. Alexandria broadens discovery by including ~1,800 newly annotated genes overlooked by previous reagents and covers 20,381 genes (~99.8% of ENSEMBL) with 4 sgRNAs per gene (2 pairs) to support confident hit calling across cell types and states. All PRCISR™ libraries are produced with Vivlion's 3Cs technology, which utilizes the oligo pool directly and avoids PCR bias and cloning artefacts-yielding highly uniform gRNA distributions that preserve representation even in down-scaled screens (e.g., limited primary or iPSC material). Building on this, our library formats decouple sequence diversity from distribution, so users can deploy single-targeting, fixed-pair, or multiplex designs as their biology demands. In practice, Alexandria enables researchers to identify context-dependent dependencies, explore pathway mechanisms, paralog buffering, and prioritise actionable targets that standard screens may miss. To streamline execution, Vivlion offers pooled and optical pooled screening, bioinformatics support, leveraging ReCo, our automated NGS read-counting pipeline for single and combinatorial CRISPR data that simplifies downstream analysis. By combining advanced CRISPR screening with uniform, low-coverage reagents like Alexandria, researchers can accelerate discovery across disease and non-disease contexts alike.
利益披露 Disclosure
E. Vialetto, Vivlion GmbH Other, financial relationship with Vivlion GmbH (employment). R. Cetin, Vivlion GmbH financial relationship with Vivlion GmbH (employment). S. Süsser, None. S. Rastogi, Vivlion GmbH Other, financial relationship with Vivlion GmbH (employment). A. Hinchie, Vivlion GmbH Other, financial relationship with Vivlion GmbH (employment). J. Martyn, Vivlion GmbH financial relationship with Vivlion GmbH (employment). M. Wegner, Vivlion GmbH Other, financial relationship with Vivlion GmbH (employment). M. Kaulich, Vivlion GmbH Other, I am founder, shareholder and employee of Vivlion.

在会议检索中打开